Vasalgel continues to be in the news spotlight

Vasalgel has enjoyed significant media presence recently which is continuing into 2015. The Santa Fe Reporter highlighted the advancements that Vasalgel promises to bring to both men and women in controlling their reproduction. Reporter Hunter Riley interviewed Parsemus Foundation Director Elaine Lissner who noted that Vasalgel is a “win-win” for everybody. The article elucidates the benefits to women who are currently relying on hormone-based birth control (which carry significant side effects) and highlights the benefits of reducing unplanned pregnancy.

Linda Brent, PhD

Executive Director, Parsemus Foundation

Tell us what you think

This form does not collect your email address. If you would like us to respond, please send questions to
This field is for validation purposes and should be left unchanged.
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today